Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Rated “Hold” by Sell-Side Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received an average rating of “Hold” from the fifteen ratings firms that are covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $32.54.

ACHC has been the topic of several research analyst reports. Leerink Partners increased their price target on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a report on Wednesday, September 23rd. TD Cowen upped their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. KeyCorp increased their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Wall Street Zen upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Guggenheim raised their target price on shares of Acadia Healthcare from $39.00 to $41.00 and gave the company a “buy” rating in a research note on Friday.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently made changes to their positions in the stock. Aberdeen Group plc raised its stake in Acadia Healthcare by 29.7% in the third quarter. Aberdeen Group plc now owns 678,378 shares of the company’s stock valued at $18,655,000 after purchasing an additional 155,415 shares in the last quarter. Allworth Financial LP raised its stake in shares of Acadia Healthcare by 30.8% in the third quarter. Allworth Financial LP now owns 1,976 shares of the company’s stock worth $58,000 after buying an additional 465 shares during the period. Russell Investments Group Ltd. grew its holdings in shares of Acadia Healthcare by 73.8% in the third quarter. Russell Investments Group Ltd. now owns 121,905 shares of the company’s stock worth $3,352,000 after purchasing an additional 51,755 shares during the last quarter. Fifth Third Bancorp grew its holdings in Acadia Healthcare by 62.9% during the third quarter. Fifth Third Bancorp now owns 184,629 shares of the company’s stock worth $5,077,000 after acquiring an additional 71,304 shares during the period. Finally, Maryland State Retirement & Pension System increased its position in shares of Acadia Healthcare by 54.8% during the 3rd quarter. Maryland State Retirement & Pension System now owns 20,674 shares of the company’s stock worth $569,000 after purchasing an additional 7,316 shares during the last quarter.

Acadia Healthcare Price Performance

ACHC stock opened at $37.00 on Monday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The business’s fifty day moving average price is $29.40 and its 200 day moving average price is $26.14. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $39.38. The company has a market capitalization of $3.44 billion, a PE ratio of -2.97, a P/E/G ratio of 9.54 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.14. The company had revenue of $895.31 million for the quarter, compared to analyst estimates of $877.76 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period last year, the company earned $0.72 earnings per share. On average, sell-side analysts anticipate that Acadia Healthcare will post 1.59 EPS for the current year.

Acadia Healthcare News Roundup

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter EPS of $0.60, ahead of the $0.46 consensus, and revenue of $895.3 million, above estimates and up 5.1% year over year. The company also raised its full-year guidance, with its outlook described as slightly above expectations. Article
• Positive Sentiment: Guggenheim raised its target to $41 and kept a Buy rating; RBC lifted its target from $31 to $41 and maintained Outperform. These revisions reinforce optimism about further gains. Article Article
• Neutral Sentiment: Cantor Fitzgerald raised its target to $39 but retained a Neutral rating, signaling a more cautious view than the bullish analyst calls. Analyst rating
• Negative Sentiment: Quarterly EPS was below the $0.72 reported a year earlier. Barclays raised its target to $35 but kept an Equal Weight rating; that target is below the cited current share price, suggesting limited upside in its view. Analyst rating

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.